XM does not provide services to residents of the United States of America.
J
J

JPMorgan

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

REUTERS SPORTS SCHEDULE AT 2 P.M. GMT/ 10 A.M. ET

REUTERS SPORTS SCHEDULE AT 2 P.M. GMT/ 10 A.M. ET Here are the top sports stories and upcoming coverage plans for Reuters text service as of 2 P.M. GMT/ 10 A.M. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect . TOP STORIES SOCCER-SPAIN-MAD/CAMAVINGA Real Madrid midfielder Camavinga to miss start of season with knee injury Real Madrid's French midfielder Eduardo Camavinga will miss the start of the season after suffering a knee injury during training fo
J

Where Wall Street bosses stand on presidential candidates Trump and Harris

FACTBOX-Where Wall Street bosses stand on presidential candidates Trump and Harris WASHINGTON, Aug 14 (Reuters) - Democratic presidential candidate Kamala Harris and Republican rival Donald Trump are locked in a tight race ahead of the November presidential election and some on Wall Street are picking sides. Here's what we know about how some of Wall Street's top bosses are leaning.
J

Global banks' tech revival sparks hope for $254 bln Indian IT sector

Global banks' tech revival sparks hope for $254 bln Indian IT sector By Sai Ishwarbharath B and Haripriya Suresh BENGALURU, Aug 14 (Reuters) - Global banks have started reviving the technology projects they put on ice in 2023, raising hopes for the $254 billion Indian IT sector that makes about a third of its revenue from banking, financial services and insurance (BFSI) clients.
I
J

Asian bonds attract hefty inflows on US rate outlook, strong exports

GRAPHIC-Asian bonds attract hefty inflows on US rate outlook, strong exports Aug 14 (Reuters) - Foreign investors were net buyers of Asian bonds for the third consecutive month in July, spurred by strong regional export growth and expectations of a September rate cut by the U.S. Federal Reserve. Overseas investors purchased a net $7.91 billion worth of bonds in Indonesia, India, Malaysia, South Korea and Thailand in July, data from regulatory authorities and bond market associations showed, foll
J

Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion

UPDATE 1-Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion Adds CEO quote in paragraph 7 and additional details about timing By Echo Wang NEW YORK, Aug 13 (Reuters) - Buyout firm Carlyle Group CG.O struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. The proceeds from the deal, which is expected to close by early 2025, will help medical-device maker Baxter reduce its debt pile.
G
J

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.